1. Home
  2. STIM vs ANIX Comparison

STIM vs ANIX Comparison

Compare STIM & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

N/A

Current Price

$2.34

Market Cap

120.4M

Sector

Health Care

ML Signal

N/A

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

N/A

Current Price

$3.11

Market Cap

103.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STIM
ANIX
Founded
2003
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
103.9M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
STIM
ANIX
Price
$2.34
$3.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$6.00
★ $9.67
AVG Volume (30 Days)
★ 1.1M
173.3K
Earning Date
11-04-2026
09-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.25
12.82
EPS
★ N/A
N/A
Revenue
★ $52,776,000.00
$210,000.00
Revenue This Year
$8.63
N/A
Revenue Next Year
$9.24
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$2.32
52 Week High
$3.44
$5.46

Technical Indicators

Market Signals
Indicator
STIM
ANIX
Relative Strength Index (RSI) 50.93 53.68
Support Level $1.19 $2.51
Resistance Level $2.31 $3.46
Average True Range (ATR) 0.25 0.22
MACD 0.04 0.02
Stochastic Oscillator 35.21 60.56

Price Performance

Historical Comparison
STIM
ANIX

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: